CIBC Private Wealth Group
BMY.RT

CIBC Private Wealth Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

CIBC Private Wealth Group’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-49,965
Closed -$34K – 1089
2020
Q4 		$34K Buy
49,965
+15,465
+45% +$32.9K ﹤0.01% 970
2020
Q3 		$78K Buy
+34,500
New +$98.5K ﹤0.01% 862
2020
Q2 		– Sell
-39,774
Closed -$151K – 856
2020
Q1 		$151K Buy
39,774
+1,745
+5% +$5.75K ﹤0.01% 809
2019
Q4 		$114K Buy
+38,029
New +$98.9K ﹤0.01% 880

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

CIBC Private Wealth Group's BMY.RT Position: Q1 2021 in Review

CIBC Private Wealth Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 49,965 shares — an estimated $34K sold.

CIBC Private Wealth Group first reported a position in BMY.RT in Q4 2019 and held it in 4 quarters. The position peaked at $151K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • CIBC Private Wealth Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • CIBC Private Wealth Group sold 49,965 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $34K.
  • CIBC Private Wealth Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 4 quarters.
  • CIBC Private Wealth Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $151K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on CIBC Private Wealth Group's 13F filing for Q1 2021, filed 12 May 2021.